Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Solco Healthcare US, LLC

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Solco Healthcare US, LLC with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Shortage of an active ingredient

Shortage details

Status
Current
Company
Solco Healthcare US, LLC
Package NDC
43547-604-10
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)
Initial Posting
Jul 14, 2023

Reason

Shortage of an active ingredient

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.